180 related articles for article (PubMed ID: 33054933)
1. Physical symptoms and psychosocial problems associated with hidradenitis suppurativa: correlation with Hurley stage.
McKenzie SA; Harview CL; Truong AK; Grogan TR; Shi VY; Bennett RG; Hsiao JL
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054933
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
Alavi A; Farzanfar D; Lee RK; Almutairi D
J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
[TBL] [Abstract][Full Text] [Related]
3. Assessing the psychological burden of patients with hidradenitis suppurativa.
Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.
Li Y; Speck P; Viera E; Siira M; Orenstein LAV
Dermatology; 2023; 239(6):1007-1012. PubMed ID: 37717562
[TBL] [Abstract][Full Text] [Related]
5. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
7. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
Pavon Blanco A; Turner MA; Petrof G; Weinman J
Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
[TBL] [Abstract][Full Text] [Related]
8. Pruritus and Malodour in Patients with Hidradenitis Suppurativa: Impact on Quality of Life and Clinical Features Associated with Symptom Severity.
Molina-Leyva A; Cuenca-Barrales C
Dermatology; 2020; 236(1):59-65. PubMed ID: 31466061
[TBL] [Abstract][Full Text] [Related]
9. Depression in patients with hidradenitis suppurativa.
Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
[TBL] [Abstract][Full Text] [Related]
10. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting quality of life in patients with hidradenitis suppurativa.
Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.
Alavi A; Anooshirvani N; Kim WB; Coutts P; Sibbald RG
Am J Clin Dermatol; 2015 Feb; 16(1):61-5. PubMed ID: 25432664
[TBL] [Abstract][Full Text] [Related]
13. AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.
Chiricozzi A; Faleri S; Franceschini C; Caro RD; Chimenti S; Bianchi L
Wounds; 2015 Oct; 27(10):258-64. PubMed ID: 26479209
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa.
Matusiak Ł; Szczęch J; Kaaz K; Lelonek E; Szepietowski JC
Acta Derm Venereol; 2018 Feb; 98(2):191-194. PubMed ID: 28971209
[TBL] [Abstract][Full Text] [Related]
15. The Handicap of Hidradenitis Suppurativa.
Deckers IE; Kimball AB
Dermatol Clin; 2016 Jan; 34(1):17-22. PubMed ID: 26617353
[TBL] [Abstract][Full Text] [Related]
16. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
[TBL] [Abstract][Full Text] [Related]
17. Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa.
Akoglu G; Yildiz I; Karaismailoğlu E; Esme P
Dermatol Ther; 2021 May; 34(3):e14910. PubMed ID: 33619860
[TBL] [Abstract][Full Text] [Related]
18. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
[TBL] [Abstract][Full Text] [Related]
19. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
Johnston L; Dupuis E; Lam L; Poelman S
J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
[TBL] [Abstract][Full Text] [Related]
20. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.
Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH
Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
